The new year brings exciting opportunities to further Research!America’s accomplishments advocating for public and private sector research, and working with our member organizations to engage the 115th Congress and new Administration. As Research!America embarks on its 29th year advocating for medical, health and scientific research, and policies in support of medical innovation, we reflect on our achievements in 2016 and begin the work of advancing priorities for this year.
Research!America worked closely with research stakeholders to increase bipartisan congressional support for the 21st Century Cures Act which was signed into law December 13, a major win for patients who will benefit from the accelerated pace of research and development. The measure is a critical step towards removing barriers to innovation, securing funding for major initiatives like the Cancer Moonshot and precision medicine, and incorporating the patient voice in drug development.
Campaign for Cures, Research!America’s national voter education initiative, focused on elevating medical and health research into the national conversation during the election season through on-the-ground events, extensive media outreach, social media and grassroots engagement, and digital advertising. Research!America held events and commissioned state-based surveys in Louisiana, Georgia and Ohio. A number of advocacy training workshops were held throughout the year to help researchers become stronger advocates for their work.
Public Health Thank You Day heightened awareness of the important work of public health professionals and the need for a public health emergency fund to improve our nation’s response to outbreaks like Zika, with a record number of organizations and individuals joining on social media.
In 2017, Research!America will step up efforts to increase funding for the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Science Foundation and the Agency for Healthcare Research and Quality. In collaboration with members and partners, the alliance will work to strengthen our global leadership in research and ensure its role in shoring up our nation’s infrastructure. Other priorities include advancing the implementation of the 21st Century Cures Act, repealing the medical device tax, sustaining the Public Health and Prevention Fund, lifting sequestration caps that could stifle research and development and slow medical progress, ensuring timely passage of the prescription drug and medical device user fee bills, and promoting a pro-innovation tax and policy climate.